Our sponsors and partners:
At Takeda Oncology, the oncology business unit brand of Takeda Pharmaceutical Company Limited, we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients.
This singular focus drives our aspiration to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, we are finding innovative ways to improve the treatment of cancer.
We’ve built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though we’ve made great strides in our fight against cancer, we are determined to do more—to work harder and to reach higher. We continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that we are today.
We know that our mission is not a quick or simple one, but we are up to the task: we aspire to cure cancer.
DNB is Norway's largest financial services group and one of the largest in the Nordic region in terms of market capitalization. The Group offers a full range of financial services, including loans, savings, advisory services, insurance and pension products for retail and corporate customers. Within DNB’s international strategy, healthcare is a prioritized area.
DNB is the Nordic Healthcare Bank and a top ranking healthcare bank in the US. The clients are serviced by bankers and industry experts located in New York, Oslo and Stockholm. The company assists international pharma clients with business development by actively monitoring the Nordic early-stage companies for promising technologies/products
Precision Oncology is proud to offer the first comprehensive, fully integrated oncology clinical development solution. We are devoted exclusively to oncology, and passionate about improving the lives of cancer patients. By combining the progressive science of biomarkers and analytics with our excellence in oncology clinical trial execution, we help innovators to invest wisely, discover value sooner and optimize the returns from research.
Our unparalleled expertise, combined with management efficiency and scientific innovation, delivers the highest quality clinical trial execution with the most advanced biomarker capabilities and processes. Our established oncology site network consistently gets trials up and running within 90-days throughout the US and Europe. With a proven track record in executing complex oncology trials and seamlessly integrated lab capabilities, Precision Oncology offers an accelerated pathway to proof-of-concept and supports our clients all the way through drug registration.
Many thanks to BIO for providing conference rooms for the 2017 International Cancer Cluster Showcase!
Biotechgate is a global life science data source covering the biotech, pharma and medtech industries. There are currently over 45,000 company profiles available with pipeline, management and financial details. Biotechgate is the ideal solution for those looking for partners, clients or funding. Biotechgate also manages regional and country portals for multiple group organisations such as OBN, Biocat, Oslo Cancer Cluster and many more.